Kingdomway(002626)2025-03-07 01:14Group 1: Company Strategy and Market Position - The company has a 50% market share in the global coenzyme Q10 raw material market, with over 95% of its raw materials sourced from China [2] - In response to the 20% additional tariffs imposed by the U.S. on Chinese goods, the company plans to increase sales prices to mitigate some of the impact [2] - The sales proportion of the company's vitamin products in the U.S. is currently very small, indicating limited impact from tariffs [2] Group 2: Product Development and Innovation - The company utilizes synthetic biology technology in products such as coenzyme Q10, NMN, NADH, vitamin K2, and others [3] - New products being developed through synthetic biology include astaxanthin, creatine, calcium pantothenate, glutathione, and various biostimulants like allulose [3] Group 3: Overseas Operations and Growth - The company's subsidiary, DRB, is experiencing steady growth and is preparing to launch new product categories [3] - The overseas health supplement factory is accelerating the integration of upstream and downstream resources, optimizing management and supply chain, leading to improved operational efficiency [3]